Visit Scipher Medicine's at booth #207
Scipher Medicine holds the fundamental belief that patients deserve simple answers to their treatment options using scientifically backed data. Scipher Medicine develops innovative diagnostic tests that predict which drug will work from day one and use the data from these tests to develop more effective therapies to improve patient outcomes. PrismRA, Scipher's first diagnostic test currently in development, identifies rheumatoid arthritis patients who will not respond to anti-TNF therapies like Humira. This will allow rheumatologists to identify alternative treatment options more quickly, resulting in better patient outcomes and reduced spend.